Brent Herspiegel is the Founder and President of Herspiegel. As a 20-year pharmaceutical industry veteran, Brent brings his substantial global consulting experience and client-side expertise to all projects. With his passion for innovative marketing and strategic planning, Brent has successfully developed Herspiegel into a trusted partner for hundreds of clients.
Since founding Herspiegel in 2007, Brent has pioneered groundbreaking approaches and set new standards to help clients succeed, while expanding the firm’s core services to address the unique needs of our clients’ US and global brands. Brent continues to focus on identifying and implementing innovative applications of technology into Herspiegel service offerings and maintaining our high level of customer satisfaction.
Brent developed his expertise in pharmaceutical marketing while working in a variety of new product planning, pre-launch, and in-line marketing and sales positions for Novo Nordisk, Eli Lilly, and Esprit Pharma (acquired by Allergan). He recognized that many clients’ needs would be best served by uniting exceptional marketing strategy and tactical implementation with a rigorous analytical mindset and approach typical of a consultancy. Brent founded Herspiegel in an effort to uniquely satisfy those needs in the marketplace.
Originally from Canada, Brent holds an MBA in the Management of Innovation and New Technology and a BS in Biochemistry from McMaster University in Hamilton, Ontario. Brent also serves as a board member of the Phi Delta Theta Canadian Educational Foundation.